p53 and ATM: cell cycle, cell death, and cancer
- PMID:9111862
- DOI: 10.1016/s0065-230x(08)60095-0
p53 and ATM: cell cycle, cell death, and cancer
Abstract
The development of a normal cell into a tumor cell appears to depend in part on mutations in genes that normally control cell cycle and cell death, thereby resulting in inappropriate cellular survival and tumorigenesis. ATM ("mutated in ataxia-telangiectasia") and p53 are two gene products that are believed to play a major role in maintaining the integrity of the genome such that alterations in these gene products may contribute to increased incidence of genomic changes such as deletions, translocations, and amplifications, which are common during oncogenesis. p53 is a critical participant in a signal transduction pathway that mediates either a G1 arrest or apoptosis in response to DNA damage. In addition, p53 is believed to be involved in the mitotic spindle checkpoint and in the regulation of centrosome function. Following certain cytotoxic stresses, normal ATM function is required for p53-mediated G1 arrest. ATM is also involved in other cellular processes such as S phase and G2-M phase arrest and in radiosensitivity. The understanding of the roles that both p53 and ATM play in cell cycle progression and cell death in response to DNA damage may provide new insights into the molecular mechanisms of cellular transformation and may help identify potential targets for improved cancer therapies.
Similar articles
- Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM.Enoch T, Norbury C.Enoch T, et al.Trends Biochem Sci. 1995 Oct;20(10):426-30. doi: 10.1016/s0968-0004(00)89093-3.Trends Biochem Sci. 1995.PMID:8533157Review.
- ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia.Lavin MF, Khanna KK.Lavin MF, et al.Int J Radiat Biol. 1999 Oct;75(10):1201-14. doi: 10.1080/095530099139359.Int J Radiat Biol. 1999.PMID:10549596Review.
- Fragments of ATM which have dominant-negative or complementing activity.Morgan SE, Lovly C, Pandita TK, Shiloh Y, Kastan MB.Morgan SE, et al.Mol Cell Biol. 1997 Apr;17(4):2020-9. doi: 10.1128/MCB.17.4.2020.Mol Cell Biol. 1997.PMID:9121450Free PMC article.
- Defective control of apoptosis, radiosensitivity, and spindle checkpoint in ataxia telangiectasia.Takagi M, Delia D, Chessa L, Iwata S, Shigeta T, Kanke Y, Goi K, Asada M, Eguchi M, Kodama C, Mizutani S.Takagi M, et al.Cancer Res. 1998 Nov 1;58(21):4923-9.Cancer Res. 1998.PMID:9810001
- Etoposide induces G2/M arrest and apoptosis in neural progenitor cells via DNA damage and an ATM/p53-related pathway.Nam C, Doi K, Nakayama H.Nam C, et al.Histol Histopathol. 2010 Apr;25(4):485-93. doi: 10.14670/HH-25.485.Histol Histopathol. 2010.PMID:20183801
Cited by
- hMutSalpha- and hMutLalpha-dependent phosphorylation of p53 in response to DNA methylator damage.Duckett DR, Bronstein SM, Taya Y, Modrich P.Duckett DR, et al.Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12384-8. doi: 10.1073/pnas.96.22.12384.Proc Natl Acad Sci U S A. 1999.PMID:10535931Free PMC article.
- Stem Cell Therapy for Hepatocellular Carcinoma: Future Perspectives.Elkhenany H, Shekshek A, Abdel-Daim M, El-Badri N.Elkhenany H, et al.Adv Exp Med Biol. 2020;1237:97-119. doi: 10.1007/5584_2019_441.Adv Exp Med Biol. 2020.PMID:31728916Review.
- Apoptosis by p53: mechanisms, regulation, and clinical implications.Sionov RV, Haupt Y.Sionov RV, et al.Springer Semin Immunopathol. 1998;19(3):345-62. doi: 10.1007/BF00787230.Springer Semin Immunopathol. 1998.PMID:9540161Review.No abstract available.
- Induced pluripotent stem cells from ataxia-telangiectasia recapitulate the cellular phenotype.Nayler S, Gatei M, Kozlov S, Gatti R, Mar JC, Wells CA, Lavin M, Wolvetang E.Nayler S, et al.Stem Cells Transl Med. 2012 Jul;1(7):523-35. doi: 10.5966/sctm.2012-0024. Epub 2012 Jun 28.Stem Cells Transl Med. 2012.PMID:23197857Free PMC article.Clinical Trial.
- Alternative telomere maintenance mechanism inAlligator sinensis provides insights into aging evolution.Guo YZ, Zhang Y, Wang Q, Yu J, Wan QH, Huang J, Fang SG.Guo YZ, et al.iScience. 2022 Dec 24;26(1):105850. doi: 10.1016/j.isci.2022.105850. eCollection 2023 Jan 20.iScience. 2022.PMID:36636341Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous